non-small-cell lung cancer
Remarkable tumor response to crizotinib in a 14-year-old girl with ALK-positive non-small-cell lung cancer.
Remarkable tumor response to crizotinib in a 14-year-old girl with <span class="gene" id="22508824-0-67-70">ALK</span>-positive <span class="disease" id="22508824-0-80-106">non-small-cell lung cancer</span>.